A mobile ECG linked to AI may help spot silent heart attacks and expand healthcare access in low-resource settings ...
Danaher , a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring devices in a surprise ...
"AI adoption is an overall positive rather than a negative, but it would change the business models of some ⁠industries. We ⁠continue to see the AI disruption trade as a rotation theme, rather than ​a ...
Feb 16 (Reuters) - Life sciences firm ⁠Danaher ⁠is closing in on ⁠a nearly $10 billion deal to acquire pulse ​oximeter maker Masimo, the Financial Times reported on Monday, citing ‌sources. Danaher ...